SCHEMBL6982683

SCHEMBL6982683

O=C1NC(=O)C(c2c[nH]c3ccc(CCc4ccccc4)cc23)=C1c1c[nH]c2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCB P05771 7/20 0.67
PRKCA P17252 6/20 0.67
CDK4 P11802 4/20 0.67
CCND1 P24385 4/20 0.67
CAMK2D Q13557 4/20 0.67
PRKACA P17612 4/20 0.67
PRKACG P22612 4/20 0.67
PRKACB P22694 4/20 0.67
CDK2 P24941 3/20 0.67
PRKCH P24723 3/20 0.67
PRKCE Q02156 3/20 0.67
PRKCQ Q04759 3/20 0.67
PRKCD Q05655 3/20 0.67
SIRT2 Q8IXJ6 2/20 0.67
CCNE2 O96020 2/20 0.67
CCNE1 P24864 2/20 0.67
ABL1 P00519 2/20 0.67
PRKD3 O94806 1/20 0.67
CCNB2 O95067 1/20 0.67
PRKCG P05129 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499673 0.83 PRKCB (0.51) PRKCBPRKCACDK4CCND1CAMK2D
Ro-316233 SCHEMBL624896 0.82 PRKCB (1.00) PRKCBPRKCACDK4CCND1CAMK2D
Ro-316233 SCHEMBL29373011 0.82 PRKCB (1.00) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL7815290 0.81 PRKCB (0.60) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL7822950 0.79 PRKCB (0.74) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL7822805 0.79 PRKCB (0.74) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL7824736 0.79 PRKCB (0.74) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL9085236 0.79 PRKCB (0.74) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL9087083 0.79 PRKCB (0.74) PRKCBPRKCACDK4CCND1CAMK2D
SCHEMBL9085391 0.79 PRKCB (0.74) PRKCBPRKCACDK4CCND1CAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1283836-A2 NEUROPROTECTIVE AND ANTI-PROLIFERATIVE COMPOUNDS Aegera Therapeutics Inc. (CA) 2003-02-19 EP disclosed
WO-2001087887-A2 NEUROPROTECTIVE AND ANTI-PROLIFERATIVE COMPOUNDS AEGERA THERAPEUTICS INC. (CA) 2001-11-22 WO disclosed